F Dx Advisors, Inc. Catalent, Inc. Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$31.86 - $67.26 $81,848 - $172,790	-2,569 Reduced 35.64%	4,639 $201,000
Q4 2022 Feb 09, 2023	BUY	$41.39 - $81.0 $66,348 - $129,843	1,603 Added 28.6%	7,208 $324,000
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $7,742 - $12,101	-107 Reduced 1.87%	5,605 $406,000
Q2 2022 Aug 03, 2022	BUY	$87.2 - $114.05 $9,417 - $12,317	108 Added 1.93%	5,712 $613,000
Q1 2022 May 03, 2022	SELL	$94.19 - $124.49 $7,252 - $9,585	-77 Reduced 1.36%	5,604 $621,000
Q4 2021 Feb 01, 2022	BUY	$119.57 - $139.07 $84,894 - $98,739	710 Added 14.28%	5,681 $727,000
Q3 2021 Oct 08, 2021	SELL	$109.17 - $142.35 $30,895 - $40,285	-283 Reduced 5.39%	4,971 $661,000
Q2 2021 Aug 05, 2021	SELL	$100.34 - $115.69 $4,515 - $5,206	-45 Reduced 0.85%	5,254 $568,000
Q1 2021 Apr 14, 2021	BUY	$101.51 - $125.27 $481,258 - $593,905	4,741 Added 849.64%	5,299 $558,000
Q1 2021 Apr 13, 2021	SELL	$101.51 - $125.27 $385,636 - $475,900	-3,799 Reduced 87.19%	558 $58,000
Q4 2020 Feb 08, 2021	BUY	$85.88 - $105.36 $48,436 - $59,423	564 Added 14.87%	4,357 $453,000
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $106,564 - $135,512	-1,465 Reduced 27.86%	3,793 $325,000
Q2 2020 Jul 22, 2020	SELL	$48.02 - $79.04 $41,393 - $68,132	-862 Reduced 14.08%	5,258 $385,000
Q1 2020 May 22, 2020	SELL	$36.95 - $62.95 $1.08 Million - $1.84 Million	-29,198 Reduced 82.67%	6,120 $318,000
Q1 2020 May 13, 2020	BUY	$36.95 - $62.95 $1.04 Million - $1.77 Million	28,112 Added 390.12%	35,318 $48,000
Q4 2019 Feb 12, 2020	SELL	$47.06 - $56.64 $3,058 - $3,681	-65 Reduced 0.89%	7,206 $406,000
Q3 2019 Nov 07, 2019	BUY	$47.45 - $58.05 $83,417 - $102,051	1,758 Added 31.89%	7,271 $347,000
Q2 2019 Jul 19, 2019	SELL	$39.26 - $54.21 $667 - $921	-17 Reduced 0.31%	5,513 $299,000
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $27,064 - $39,835	-907 Reduced 14.09%	5,530 $224,000
Q4 2018 Apr 29, 2019	SELL	$29.95 - $46.34 $868 - $1,343	-29 Reduced 0.45%	6,437 $201,000
Q4 2018 Feb 07, 2019	SELL	$29.95 - $46.34 $4,492 - $6,951	-150 Reduced 2.27%	6,466 $202,000
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $265,433 - $301,358	6,616 New	6,616 $301,000
Q1 2018 May 02, 2018	SELL	$39.4 - $47.39 $222,452 - $267,563	-5,646 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$37.27 - $43.02 $75,769 - $87,459	-2,033 Reduced 26.47%	5,646 $232,000
Q3 2017 Nov 03, 2017	BUY	$33.75 - $41.67 $30,813 - $38,044	913 Added 13.49%	7,679 $307,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,766	6,766 $237,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.28 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$406 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account